Home Public Health Lymphatic Filariasis Elimination Program updates, Nepal

Lymphatic Filariasis Elimination Program updates, Nepal

by Public Health Update

Lymphatic Filariasis Elimination Program updates, Nepal

Lymphatic Filariasis Burden in Nepal

    • Endemic districts: 61
    • Average prevalence: 13%
    • Population at risk: 25 million
    • Causative agent: Wuchereria bancrofti
    • Transmission vector : Culex quinquefasciatus
    • Reported chronic conditions : > 30,000; majority are hydrocele


Lymphatic Filariasis Elimination Program, Nepal

  • To eliminate LF as a public health problem by 2020


  • To cover with MDA all LF endemic districts by 2014 and achieve <1% prevalence in all endemic districts by 2020


  • Interruption of transmission by MDA – Diethylcarbamazine (DEC) and Albendazole, yearly campaign for six years
  • Morbidity management & Disability Prevention

LF Elimination Strategies & Steps

  • Interruption of transmission by Mass Drug Administration (MDA) using two drugs regimen, Diethylcarbamazine (DEC) and Albendazole, once yearly for six years.
  • Morbidity Management by self care and with support using intensive but simple, effective and local hygiene technique.

Monitoring and Evaluation During and After MDA

  • Coverage is monitored at each MDA round to determine whether the goal of at least 65% coverage of the total population was met.
  • After at least five rounds of effective MDA, the impact is evaluated at sentinel and spot-check sites.
  • If all the eligibility criteria are met, a transmission assessment survey (TAS) is conducted before deciding to stop MDA.
  • TAS is repeated twice during post-MDA surveillance phase.

Progress Towards LF Elimination: As of Dec 2018

  • Mapping done: 2001,2005/2006, 2012
  • Geographical Coverage: MDA started from 1 district in 2003 & Reached 100% in 2013,
  • MDA stopped in 46 districts after TAS 1
  • 2 districts are scheduled for TAS 1 in 2019
  • TAS 2 succeeded in14 districts & TAS 3 succeeded in 5 districts
  • Almost 110 million doses of MDA drugs administered.
  • Post MDA surveillance and morbidity management ongoing.
  • 12 districts completed MMDP mapping using Measure SMS Reporting and expanding rapidly.

Morbidity Management and Disability Prevention (MMDP) Status – 2018

  • Free Hydrocele Surgery done – 7327 cases (Till 2018) and free surgeries ongoing in all endemic districts.
  • Morbidity mapping completed in 12 districts and 9 more in plan for 2019 (9511 Cases)
  • Successful Integration with LF and leprosy self care in 1 (Lalgadh) Hospital & in talk with few others.

Source of Info: EDCD Presentation 


Egypt eliminates lymphatic filariasis
Diseases Control Program in Nepal : Lymphatic Filariasis
Descriptive Epidemiology of Scrub Typhus in Nepal, 2017
Bye – Bye ??? Trachoma ?‍??‍? from Nepal ??
Classification of Water-related diseases
Malaria Micro Stratification Report 2018

You may also like

Comments are closed.

Public Health Update (Sagun’s Blog) is a popular public health portal in Nepal. Thousands of health professionals are connected with Public Health Update to get up-to-date public health updates, search for jobs, and explore opportunities.
#1 Public Health Blog for sharing Job opportunities and updates in Nepal

”Public Health Information For All”
– Sagun Paudel, Founder


Contact: blog.publichealthupdate@gmail.com.

Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023. Contact us.